FOXO1 and type 2 diabetes mellitus: Furthermore, CRISPR-mediated functional studies in human islets show that the T2D transcriptional signature can be reversed by targeted inhibition of a key master regulator of dedifferentiation, BACH289, which we also characterized as an ectopically activated gene in FoxO1 knockout β-cells60.